Quantitative neuroimaging software for clinical assessment of hippocampal volumes on MR imaging

Journal of Alzheimer's Disease

Volumn 49, Issue 3, 2015, Pages 723-732

  Ahdidan, Jamila ^a   Raji, Cyrus A ^b   DeYoe, Edgar A ^c   Mathis, Jedidiah ^c   Noe, Karsten O ^d   Rimestad, Jens ^d   Kjeldsen, Thomas K ^d   Mosegaard, Jesper ^d   Becker, James T ^e   Lopez, Oscar ^f  

^a Brainreader   (Denmark)

^b UCLA MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d ALEXANDRA INSTITUTE   (Denmark)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Hippocampus; Magnetic resonance imaging; Quantification

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; DURA MATER; FEMALE; GOLD STANDARD; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VOLUMETRY; WHITE MATTER; COGNITIVE DEFECT; COMPUTER ASSISTED DIAGNOSIS; DEVICES; MIDDLE AGED; PATHOLOGY; PROCEDURES; SOFTWARE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITIVE DYSFUNCTION; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SOFTWARE;

EID: 84949942308     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150559     Document Type: Article

References (76)

1. Olton DS, Becker JT, Handelmann GE (1979) Hippocampus, space, and memory. Behav Brain Sci 2, 313-322.
2. Squire LR (1992) Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychol Rev 99, 195-231.
3. Nenadic I, Dietzek M, Schönfeld N, Lorenz C, Gussew A, Reichenbach JR, Sauer H, Gaser C, Smesny S (2015) Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: A VBM study. Schizophrenia Res 161, 169-176.
4. Singh R, Meier TB, Kuplicki R, Savitz J, Mukai I, Cavanagh L, Allen T, Teague TK, Nerio C, Polanski D, Bellgowan PSF (2014) Relationshipofcollegiate football experience and concussion with hippocampal volume and cognitive outcomes. JAMA 311, 1883.
5. Wang Z, Neylan TC, Mueller SG, Lenoci M, Truran D, Mar-mar CR, Weiner MW, Schuff N (2010) Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder. Arch Gen Psychiatry 67, 296.
6. Wisse LEM, Biessels GJ, Stegenga BT, Kooistra M, van der Veen PH, Zwanenburg JJM, van der Graaf Y, Geerlings MI (2015) Major depressive episodes over the course of 7 years and hippocampal subfield volumes at 7 tesla MRI: The PREDICT-MR study. J Affect Disord 175, 1-7.
7. Xu Y, Jack CR, O'Brien PC, Kokmen E, Smith GE, Ivnik RJ, Boeve BF, Tangalos RG, Petersen RC (2000) Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology 54, 1760-1767.
8. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC (2001) Practice parameter: Diagnosis of dementia (an evidence-based review): Reportofthe Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56, 1143-1153.
9. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert MS (2002) MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology 58, 1188-1196.
10. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hänninen T, Laakso MP, Hallikainen M, Vanhanen M, Nissi-nen A, Helkala E-L, Vainio P, Vanninen R, Partanen K, Soininen H (2004) Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 25, 303-310.
11. Kesslak JP, Nalcioglu O, Cotman CW (1991) Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 41, 51.
12. Ringman JM, Pope W, Salamon N (2010) Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer's disease. J Neurol 257, 839-842.
13. Farid N, Girard HM, Kemmotsu N, Smith ME, Magda SW, Lim WY, Lee RR, McDonald CR (2012) Temporal lobe epilepsy: Quantitative MR volumetry in detection of hip-pocampal atrophy. Radiology 264, 542-550.
14. Varon D, Barker W, Loewenstein D, Greig M, Bohorquez A, Santos I, Shen Q, Harper M, Vallejo-Luces T, Duara R, Alzheimer's Disease Neuroimaging Initiative (2015) Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: Baseline diagnosis and the prediction of MCI outcome. Int J Geriatr Psychiatry 30, 192-200.
15. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
16. Cherbuin N, Reglade-Meslin C, Kumar R, Jacomb P, Easteal S, Christensen H, Sachdev P, Anstey KJ(2009) Risk factors of transition from normal cognition to mild cognitive disorder: The PATH through Life Study. Dement Geriatr Cogn Disord 28, 47-55.
17. Boyle CP, Raji CA, Erickson KI, Lopez OL, Becker JT, Gach HM, Longstreth WT, Teverovskiy L, Kuller LH, Carmichael OT, Thompson PM (2015) Physical activity, body mass index, and brain atrophy in Alzheimer's disease. Neurobiol Aging36, S194-S202.
18. Fotuhi M, Do D, Jack C (2012) Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol 8, 189-202.
19. Raji CA, Erickson KI, Lopez OL, Kuller LH, Gach HM, Thompson PM, Riverol M, Becker JT (2014) Regular fish consumption and age-related brain gray matter loss. Am J Prev Med 47, 444-451.
20. Raji CA, Ho AJ, Parikshak NN, Becker JT, Lopez OL, Kuller LH, Hua X, Leow AD, Toga AW, Thompson PM (2010) Brain structure and obesity. Hum Brain Mapp 31, 353-364.
21. Erickson KI, Raji CA, Lopez OL, Becker JT, Rosano C, Newman AB, Gach HM, Thompson PM, Ho AJ, Kuller LH (2010) Physical activity predicts gray matter volume in late adulthood: The Cardiovascular Health Study. Neurology 75, 1415-1422.
22. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E, Kramer AF (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci USA 108, 3017-3022.
23. Raji CA, Wei SH, Bredesen DE, Moylan S, Law M, Small GW, Thompson PM, Friedlander RM, Silverman DH, Baune BT, Hoang TA, Salamon N, Vernooij MW (2015) Hot topics in research: Preventive neuroradiology in brain aging and cognitive decline. AJNR Am J Neuroradiol, doi: 10.3174/ajnr.A4409
24. Varma VR, Chuang YF, Harris GC, Tan EJ, Carlson MC (2015) Low-intensity daily walking activity is associated with hippocampal volume in older adults. Hippocampus 25, 605-615.
25. Alzheimer's Association(2015) Alzheimer's disease facts and figures. Alzheimers Dement 11, 332-384.
26. Strain JF, Womack KB, Didehbani N, Spence JS, Conover H, Hart J Jr, Kraut MA, Cullum CM (2015) Imaging correlates of memory and concussion history in retired National Football League athletes. JAMA Neurol 72, 773-780.
27. Gurvits TV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, Orr SP, Kikinis R, Jolesz FA, McCarley RW, Pitman RK (1996) Magnetic resonance imaging study of hip-pocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry 40, 1091-1099.
28. Wignall EL, Dickson JM, Vaughan P, Farrow TFD, Wilkinson ID, Hunter MD, Woodruff PWR (2004) Smaller hippocam-pal volume in patients with recent-onset posttraumatic stress disorder. Biol Psychiatry 56, 832-836.
29. Abdallah CG, Salas R, Jackowski A, Baldwin P, Sato JR, Mathew SJ (2015) Hippocampal volume and the rapid antidepressant effect of ketamine. J Psychopharmacol 29, 591-595.
30. Ishiwata A, Mizumura S, Mishina M, Yamazaki M, Katayama Y (2014) The potentially protective effect of donepezil in Alzheimer's disease. Dement Geriatr Cogn Disord 38, 170-177.
31. Redlich R, Almeida JJR, Grotegerd D, Opel N, Kugel H, Heindel W, Arolt V, Phillips ML, Dannlowski U (2014) Brain morphometric biomarkers distinguishing unipolar and bipolar depression. JAMA Psychiatry 71, 1222.
32. Haukvik UK, Westlye LT, Mørch-Johnsen L, Jørgensen KN, Lange EH, Dale AM, Melle I, Andreassen OA, Agartz I(2015) In vivo hippocampal subfield volumes in schizophrenia and bipolar disorder. Biol Psychiatry 77, 581-588.
33. Benedict RHB, Ramasamy D, Munschauer F, Weinstock-Guttman B, Zivadinov R (2009) Memory impairment in multiple sclerosis: Correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 80, 201-206.
34. Moran NF, Lemieux L, Kitchen ND, Fish DR, Shorvon SD (2001) Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis. Brain 124, 167-175.
35. Mueller SG, Laxer KD, Barakos J, Cheong I, Garcia P, Weiner MW(2009) Subfield atrophy pattern intemporal lobe epilepsy with and without mesial sclerosis detected by high-resolution MRI at 4 Tesla: Preliminary results. Epilepsia 50, 1474-1483.
36. de Lanerolle NC, Lee TS (2005) New facets of the neu-ropathology and molecular profile of human temporal lobe epilepsy. Epilepsy Behav 7, 190-203.
37. Téllez-Zenteno JF, Hernández-Ronquillo L (2012) A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res Treat 2012, 1-5.
38. Ver Hoef LW, Williams FB, Kennedy RE, Szaflarski JP, Knowlton RC (2013) Predictivevalueofhippocampal internal architecture asymmetry in temporal lobe epilepsy. Epilepsy Res 106, 155-163.
39. Rodrigue KM (2004) Shrinkage of the entorhinal cortex over five years predicts memory performance in healthy adults. J Neurosci 24, 956-963.
40. Ezekiel F, Chao L, Kornak J, Du AT, Cardenas V, Truran D, Jagust W, Chui H, Miller B, Yaffe K, Schuff N, Weiner M (2004) Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary shift integral versus tracing of the entorhinal cortex and hippocampus. Alzheimer Dis Assoc Disord 18, 196-201.
41. Boccardi M, Bocchetta M, Apostolova LG, Preboske G, Robitaille N, Pasqualetti P, Collins LD, Duchesne S, Jack CR, Frisoni GB (2013) Establishing magnetic resonance images orientation for the EADC-ADNI manual hippocampal segmentation protocol. J Neuroimaging 24, 509-514.
42. Bocchetta M, Boccardi M, Ganzola R, Apostolova LG, Pre-boske G, Wolf D, Ferrari C, Pasqualetti P, Robitaille N, Duchesne S, Jack CR, Frisoni GB (2015) Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project. Alzheimers Dementia 11, 151-160.e155.
43. Hirata Y, Matsuda H, Nemoto K, Ohnishi T, Hirao K, Yamashita F, Asada T, Iwabuchi S, Samejima H(2005) Voxel-based morphometryto discriminate early Alzheimer's disease from controls. Neurosci Lett 382, 269-274.
44. Barnes J, Bartlett JW, van de Pol LA, Loy CT, Scahill RI, Frost C, Thompson P, Fox NC (2009) A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging 30, 1711-1723.
45. Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, De Carli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DLG, Johnson K, Mangin J-F, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NL (2011) Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement 7, 474-485.e474.
46. Boccardi M, Bocchetta M, Ganzola R, Robitaille N, Redolfi A, Duchesne S, Jack CR Jr, Frisoni GB, Segmentation E-AWGoTHPfMH, for the Alzheimer's Disease Neuroimaging, Initiative (2015) Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation. Alzheimers Dement 11, 184-194.
47. Duchesne S, Valdivia F, Robitaille N, Mouiha A, Valdivia FA, Bocchetta M, Apostolova LG, Ganzola R, Preboske G, Wolf D, Boccardi M, Jack CR Jr, Frisoni GB, Working Group on The Harmonized Protocol for Manual Hippocam-pal Segmentation EADC-ADNI, for the Alzheimer's Disease Neuroimaging, Initiative (2015) Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project. Alzheimers Dement 11, 161-174.
48. Frisoni GB, Jack CR Jr, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehericy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel S, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, Duchesne S, Duvernoy H, Boccardi M, Working Group on The Harmonized Protocol for Manual Hippocampal Volume-try EADC-ADNI, for the Alzheimer's Disease Neuroimaging, Initiative (2015) The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity. Alzheimers Dement 11, 111-125.
49. Boccardi M, Bocchetta M, Morency FC, Collins DL, Nishikawa M, Ganzola R, Grothe MJ, Wolf D, Redolfi A, Pievani M, Antelmi L, Fellgiebel A, Matsuda H, Teipel S, Duchesne S, Jack CR Jr, Frisoni GB, Working Group on The Harmonized Protocol for Manual Hippocampal Segmentation EADC-ADNI, for the Alzheimer's Disease Neuroimaging, Initiative (2015) Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol. Alzheimers Dement 11, 175-183.
50. Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, Camicioli R, Csernansky JG, de Leon MJ, deToledo-Morrell L, Killiany RJ, Lehericy S, Pantel J, Pruess-ner JC, Soininen H, Watson C, Duchesne S, Jack CR Jr, Frisoni GB (2011) Surveyofprotocols for the manual segmentation of the hippocampus: Preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis 26(Suppl 3), 61-75.
51. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, J, Ward LW, Dale C, Felmlee AM, Gunter JP, Hill JL, Killiany DL, Schuff R, Fox-Bosetti N, Lin S, Studholme C, DeCarli C, Krueger CS, Ward G, Metzger HA, Scott GJ, Mallozzi KT, Blezek R, Levy D, Debbins J, Fleisher JP, Albert AS, Green M, Bartzokis R, Glover G, Mugler G, Weiner J, MW (2008) The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27, 685-691.
52. Ahdidan J, Hviid LB, Chakravarty MM, Ravnkilde B, Rosenberg R, Rodell A, Stødkilde-Jørgensen H, Videbech P (2011) Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder. Acta Psychiatr Scand 123, 211-219.
53. Dice LR (1945) Measures of the amount of ecologic association between species. Ecology 26, 297.
54. Shen Q (2011) Volumetric analysis of brain MRI for Alzheimer's disease. Open Access Dissertations, Paper 526.
55. Zou KH, Warfield SK, Bharatha A, Tempany CMC, Kaus MR, Haker SJ, Wells WM, Jolesz FA, Kikinis R (2004) Statistical validation of image segmentation quality based on a spatial overlap index1. Acad Radiol 11, 178-189.
56. Tustison NJ, Avants BB, Cook PA, Yuanjie Z, Egan A, Yushkevich PA, Gee JC (2010) N4ITK: Improved N3 Bias Correction. IEEE Trans Med Imaging 29, 1310-1320.
57. Carmichael OT, Aizenstein HA, Davis SW, Becker JT, Thompson PM, Meltzer CC, Liu Y (2005) Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage 27, 979-990.
58. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Hasel-grove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341-355.
59. Ourselin S, Roche A, Subsol G, Pennec X, Ayache N (2001) Reconstructing a 3D structure from serial histological sections. Image Vis Comput 19, 25-31.
60. Modat M, Ridgway GR, Taylor ZA, Lehmann M, Barnes J, Hawkes DJ, Fox NC, Ourselin S (2010) Fast free-form deformation using graphics processing units. Comput Methods Programs Biomed 98, 278-284.
61. Winston GP, Cardoso MJ, Williams EJ, Burdett JL, Bartlett PA, Espak M, Behr C, Duncan JS, Ourselin S (2013) Automated hippocampal segmentation in patients with epilepsy: Available free online. Epilepsia 54, 2166-2173.
62. Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, Thompson PM, Schuff N, Krueger G, Killiany RJ, Decarli CS, Dale AM, Carmichael OW, Tosun D, Weiner MW, Alzheimer's Disease Neuroimaging, Initiative (2010) Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement 6, 212-220.
63. Cohen J (1988) Statistical power analysis for the behavioral sciences, Lawrence Earlbaum Associates, Hillsdale, NJ.
64. Ochs AL, Ross DE, Zannoni MD, Abildskov TJ, Bigler ED (2015) Comparison of automated brain volume measures obtained with Neuro Quant (R) and Free Surfer. J Neuroimag-ing 25, 721-727.
65. Lehmann M, Douiri A, Kim LG, Modat M, Chan D, Ourselin S, Barnes J, Fox NC (2010) Atrophy patterns in Alzheimer's disease and semantic dementia: A comparison of Free Surfer and manual volumetric measurements. Neuroimage 49, 2264-2274.
66. Sanchez-Benavides G, Gomez-Anson B, Sainz A, Vives Y, Delfino M, Pena-Casanova J (2010) Manual validation of Free Surfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer disease subjects. Psychiatry Res 181, 219-225.
67. Mulder ER, de Jong RA, Knol DL, van Schijndel RA, Cover KS, Visser PJ, Barkhof F, Vrenken H, Alzheimer's disease Neuroimaging Initiative (2014) Hippocampal volume change measurement: Quantitative assessment of the reproducibil-ity of expert manual outlining and the automated methods Free Surfer and FIRST. Neuroimage 92, 169-181.
68. Kirson N, Hunter C, Desai U, Cummings A, San Roman A, Faries D, Hardwick C, Birnbaum H (2013) Excess costs associated with misdiagnosis of Alzheimer's disease among U.S. Medicare beneficiaries with vascular dementia or Parkinson's disease. Alzheimers Dement 9, P845-P846.
69. Brewer JB (2009) Fully-automated volumetric MRI with normative ranges: Translation to clinical practice. Behav Neurol 21, 21-28.
70. Ramani A, Jensen JH, Helpern JA (2006) Quantitative MR imaging in Alzheimer disease. Radiology 241, 26-44.
71. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang G-F, Estrada S, Austin B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid inAlzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55, 306-319.
72. Hughes S (2013) Mixed reaction to CMS decision on amyloid PET imaging. Medscape, July 19, 2013, http://www. medscape.com/viewarticle/808149, Accessed Ma 1, 2015.
73. Alzheimer's Association. For Healthcare Professionals: Frequently asked questions about beta-amyloid imaging, http://www.alz.org/documents custom/hcp faq auc.pdf
74. Desikan RS, Rafii MS, Brewer JB, Hess CP (2013) An expanded role for neuroimaging in the evaluation of memory impairment. AJNR Am J Neuroradiol 34, 2075-2082.
75. Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, Ortega BN, Zaiko YV, Roach EL, Kor-gaonkar MS, Grieve SM, Galatzer-Levy I, Fox PT, Etkin A (2015) Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 72, 305-315.
76. Perez-Miralles FC, Sastre-Garriga J, Vidal-Jordana A, Rio J, Auger C, Pareto D, Tintore M, Rovira A, Montalban X (2015) Predictive value of early brain atrophy on response in patients treated with interferon beta. Neurol Neuroimmunol Neuroinflamm 2, e132.